Searched for
DERMA MARKET
Fable 5's cost challenge; Opendoor's India exitAnthropic's Fable 5 could rewrite how IT works, but the price tag and performance quirks raise hard questions. This and more in today’s ETt...- Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...
- Can Honasa shares rally up to 57% after strong Q4 show? Jefferies, CLSA & two other brokerages weigh inHonasa Consumer shares surged over 11% on Friday after a strong Q4 FY26 performance, with brokerages including Jefferies, CLSA, ICICI Secur...
- Honasa Consumer Q4 results: Profit more than doubles to Rs 69 cr; co declares Rs 3 dividendHonasa Consumer reported Q4 FY26 profit more than doubled to Rs 69 crore and record revenue of Rs 682 crore (28% YoY). Full-year PAT reache...
- Mamaearth parent Honasa Consumer may become first new-age company to announce dividendHonasa Consumer’s board will consider a final dividend on May 21 alongside Q4 FY26 results, potentially making Mamaearth’s parent the first...
- Mamaearth parent Honasa Consumer estimates over 20% revenue growth in Q4Honasa Consumer expects steady March-quarter growth, though reported revenue may appear lower due to changes in revenue recognition in rela...
- Nationwide soap recall sparks sepsis fears — check your bathroom nowDermaRite Industries has initiated a nationwide recall of several hygiene products, including popular soaps and cleansers used in hospitals...
- Drug sales get a monsoon twist in AugustLiver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related il...
- Derma products market seeing strong growthIndustry data shows emollients, protectives, have grown from Rs 1,390 crore MAT value in April 2022 to Rs 1,892 crore in April 2024. Likewi...
- Mamaearth shares rally 8% as The Derma Co hits Rs 500 crore revenue milestoneHonasa Consumer, the parent company of skincare brand The Derma Co., saw its shares surge by up to 7.6% to Rs 435 on BSE after announcing T...
- Skincare brand The Derma Co crossed Rs 350 crore annual revenue rate in June quarter“The Derma Co was conceived with the aim to democratise the segment of active ingredients-based skincare and make it easily accessible to c...
- IPO-bound Honasa's The Derma Co likely set for Rs 350 crore in annual recurring revenueThe Derma Co, owned by Honasa Consumer, has announced that its monthly revenue has exceeded Rs 30 crore, paving way for an annual recurring...
- Honasa Consumer acquires majority stake in skincare brand Dr. Sheth's"While HCPL has control of the majority stake in Dr Sheth's, Dr Aneesh Sheth will continue to lead the business and product innovation for ...
- Buy Aurobindo Pharma, target Rs 836: Elara CapitalBuy Aurobindo Pharma Ltd. at a price target of Rs 836.
- Cipla acquires marketing rights of derma player Percos IndiaCipla has acquired the exclusive rights to market skin care products of the country’s leading derma and cosmeceutical player Percos India.
- Torrent Pharma rallies 5%, hits 52-week high on acquisition plansTorrent Pharma pared some of the morning gains but was still trading 3.5 per cent higher at Rs 1315.80. It hit a low of Rs 1306 and a high ...
- Lupin rallies over 1% on acquisition plans, USFDA HIV drug approvalLupin Ltd rallied as much as 1.5 per cent in trade on Monday on reports that that the drug major is eyeing acquisitions in various global m...
- Kaya expects break-even by 2013, eyes Rs 500 cr revenue by FY'15Marico's beauty and wellness arm, Kaya, expects to grow into a Rs 500 crore company in the next three to four years.
- Marico acquires aesthetic skin-care biz in SingaporeFMCG major, Marico, today announced the acquisition of the aesthetics business of Singapore-based Derma Rx Asia Pacific (Derma Rx), through...
- Cadila buys out Liva in an all-cash dealZydus Group’s Cadila Healthcare has acquired Mumbai-based Liva Healthcare, a mid-sized Indian pharma company with a dermatology-focused pro...
Load More
